236 related articles for article (PubMed ID: 35360109)
1. Detection of
Périchon B; Lichtl-Häfele J; Bergsten E; Delage V; Trieu-Cuot P; Sansonetti P; Sobhani I; Dramsi S
Front Cell Infect Microbiol; 2022; 12():794391. PubMed ID: 35360109
[TBL] [Abstract][Full Text] [Related]
2. Association of Antibody Responses to Fusobacterium nucleatum and Streptococcus gallolyticus Proteins with Colorectal Adenoma and Colorectal Cancer.
Genua F; Butt J; Waterboer T; Hughes DJ
Dig Dis Sci; 2023 Aug; 68(8):3300-3311. PubMed ID: 37338617
[TBL] [Abstract][Full Text] [Related]
3. Association between colorectal cancer and Fusobacterium nucleatum and Bacteroides fragilis bacteria in Iranian patients: a preliminary study.
Shariati A; Razavi S; Ghaznavi-Rad E; Jahanbin B; Akbari A; Norzaee S; Darban-Sarokhalil D
Infect Agent Cancer; 2021 Jun; 16(1):41. PubMed ID: 34108031
[TBL] [Abstract][Full Text] [Related]
4. The presence of bacteria varies between colorectal adenocarcinomas, precursor lesions and non-malignant tissue.
Bundgaard-Nielsen C; Baandrup UT; Nielsen LP; Sørensen S
BMC Cancer; 2019 Apr; 19(1):399. PubMed ID: 31035942
[TBL] [Abstract][Full Text] [Related]
5. High frequency of enterotoxigenic Bacteroides fragilis and Enterococcus faecalis in the paraffin-embedded tissues of Iranian colorectal cancer patients.
Khodaverdi N; Zeighami H; Jalilvand A; Haghi F; Hesami N
BMC Cancer; 2021 Dec; 21(1):1353. PubMed ID: 34937552
[TBL] [Abstract][Full Text] [Related]
6. Quantitative profiling of colorectal cancer-associated bacteria reveals associations between fusobacterium spp., enterotoxigenic Bacteroides fragilis (ETBF) and clinicopathological features of colorectal cancer.
Viljoen KS; Dakshinamurthy A; Goldberg P; Blackburn JM
PLoS One; 2015; 10(3):e0119462. PubMed ID: 25751261
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of pks + bacteria and enterotoxigenic Bacteroides fragilis in patients with colorectal cancer.
Oliero M; Hajjar R; Cuisiniere T; Fragoso G; Calvé A; Dagbert F; Loungnarath R; Sebajang H; Schwenter F; Wassef R; Ratelle R; De Broux É; Richard CS; Santos MM
Gut Pathog; 2022 Dec; 14(1):51. PubMed ID: 36578036
[TBL] [Abstract][Full Text] [Related]
8. The Bacteroides fragilis toxin gene is prevalent in the colon mucosa of colorectal cancer patients.
Boleij A; Hechenbleikner EM; Goodwin AC; Badani R; Stein EM; Lazarev MG; Ellis B; Carroll KC; Albesiano E; Wick EC; Platz EA; Pardoll DM; Sears CL
Clin Infect Dis; 2015 Jan; 60(2):208-15. PubMed ID: 25305284
[TBL] [Abstract][Full Text] [Related]
9. [Expression of enterotoxigenic Bacteroides fragilis and polyketide synthase gene-expressing Escherichia coli in colorectal adenoma patients].
Xie LL; Wu N; Zhu YM; Qiu XY; Chen GD; Zhang LM; Liu YL
Zhonghua Yi Xue Za Zhi; 2016 Mar; 96(12):954-9. PubMed ID: 27045721
[TBL] [Abstract][Full Text] [Related]
10. Association Between Bacteremia From Specific Microbes and Subsequent Diagnosis of Colorectal Cancer.
Kwong TNY; Wang X; Nakatsu G; Chow TC; Tipoe T; Dai RZW; Tsoi KKK; Wong MCS; Tse G; Chan MTV; Chan FKL; Ng SC; Wu JCY; Wu WKK; Yu J; Sung JJY; Wong SH
Gastroenterology; 2018 Aug; 155(2):383-390.e8. PubMed ID: 29729257
[TBL] [Abstract][Full Text] [Related]
11. Intestinal microbiota and its association with colon cancer and red/processed meat consumption.
Abu-Ghazaleh N; Chua WJ; Gopalan V
J Gastroenterol Hepatol; 2021 Jan; 36(1):75-88. PubMed ID: 32198788
[TBL] [Abstract][Full Text] [Related]
12. Intratumoral presence of the genotoxic gut bacteria pks
Joo JE; Chu YL; Georgeson P; Walker R; Mahmood K; Clendenning M; Meyers AL; Como J; Joseland S; Preston SG; Diepenhorst N; Toner J; Ingle DJ; Sherry NL; Metz A; Lynch BM; Milne RL; Southey MC; Hopper JL; Win AK; Macrae FA; Winship IM; Rosty C; Jenkins MA; Buchanan DD
Br J Cancer; 2024 Mar; 130(5):728-740. PubMed ID: 38200234
[TBL] [Abstract][Full Text] [Related]
13. Fecal
Shen X; Li J; Li J; Zhang Y; Li X; Cui Y; Gao Q; Chen X; Chen Y; Fang JY
Front Oncol; 2021; 11():661048. PubMed ID: 34046355
[TBL] [Abstract][Full Text] [Related]
14. [The Relationship of Enterotoxigenic Bacteroides fragilis and Fusobacterium nucleatum Intestinal Colonization with Colorectal Cancer: A Case-Control Study Performed with Colon Biopsies].
Öztürk Bakar Y; Demiryas S; Ceylan Kılınçarslan A; Demirci M; Kepil N; Bakar MT; Taner Z; Tokuç E; Ziyad MA; Taşçı İ; Kocazeybek BS; Bahar Tokman H
Mikrobiyol Bul; 2023 Jul; 57(3):353-364. PubMed ID: 37462300
[TBL] [Abstract][Full Text] [Related]
15. Serology of Streptococcus gallolyticus subspecies gallolyticus and its association with colorectal cancer and precursors.
Butt J; Werner S; Willhauck-Fleckenstein M; Michel A; Waterboer T; Zörnig I; Boleij A; Dramsi S; Brenner H; Pawlita M
Int J Cancer; 2017 Sep; 141(5):897-904. PubMed ID: 28477334
[TBL] [Abstract][Full Text] [Related]
16. The association between fecal enterotoxigenic B. fragilis with colorectal cancer.
Haghi F; Goli E; Mirzaei B; Zeighami H
BMC Cancer; 2019 Sep; 19(1):879. PubMed ID: 31488085
[TBL] [Abstract][Full Text] [Related]
17. Enterotoxigenic
Zamani S; Taslimi R; Sarabi A; Jasemi S; Sechi LA; Feizabadi MM
Front Cell Infect Microbiol; 2019; 9():449. PubMed ID: 32010637
[TBL] [Abstract][Full Text] [Related]
18. Aspirin Modulation of the Colorectal Cancer-Associated Microbe Fusobacterium nucleatum.
Brennan CA; Nakatsu G; Gallini Comeau CA; Drew DA; Glickman JN; Schoen RE; Chan AT; Garrett WS
mBio; 2021 Apr; 12(2):. PubMed ID: 33824205
[TBL] [Abstract][Full Text] [Related]
19. Fusobacterium nucleatum and Bacteroides fragilis detection in colorectal tumours: Optimal target site and correlation with total bacterial load.
Rye MS; Garrett KL; Holt RA; Platell CF; McCoy MJ
PLoS One; 2022; 17(1):e0262416. PubMed ID: 34995318
[TBL] [Abstract][Full Text] [Related]
20. Detection of Streptococcus gallolyticus in colorectal cancer and inflammatory bowel disease patients compared to control group in southwest of Iran.
Sheikh AF; Masjedi Zadeh AR; Saki M; Khani P; Hashemi SJ; Shahin Zadeh S; Dastoorpoor M
Mol Biol Rep; 2020 Nov; 47(11):8361-8365. PubMed ID: 33128683
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
